Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19

(Reuters) – Canadian drug discovery technology company AbCellera, which analyzes and identifies antibodies for pharmaceutical companies working on a coronavirus treatment and other medicines, said on Wednesday it had raised $105 million in funds. AbCellera has been working with pharmaceutical … Continue reading Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19

Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19

FILE PHOTO: A woman holds a small bottle labeled with a “Vaccine COVID-19” sticker and a medical syringe in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo (Reuters) – Canadian drug discovery technology company AbCellera, which analyzes and identifies … Continue reading Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19